Cargando…

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer

Immune checkpoint inhibitors have revolutionized the treatment of bladder urothelial cancers and have wide application in almost all disease states. Although several drugs have initially been shown to be beneficial in the second-line metastatic setting, there are still ongoing controversies and deba...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhea, Logan P, Aragon-Ching, Jeanny B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481722/
https://www.ncbi.nlm.nih.gov/pubmed/34602833
http://dx.doi.org/10.1177/11795549211044963